|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Steve Martin To Replace Reg Jones As CFO Of Stratagene; Reg Jones To Retire Effective June 30, 2005
10/19/2005 5:09:54 PM
LA JOLLA, Calif.--(BUSINESS WIRE)--May 20, 2005--Stratagene Corporation (Nasdaq:STGN), a developer, marketer and manufacturer of life science research and diagnostic products, today announced that Steve Martin, Director of Finance, will succeed Reg Jones as CFO on July 1, 2005. Mr. Jones is retiring after a 24-year career with Stratagene and Hycor Biomedical Inc., which was acquired by Stratagene on June 2, 2004. Mr. Jones will remain in a consulting capacity with Stratagene.
"When Steve joined the company in May 2004, we viewed him as a potential future CFO of our company," said Joseph A. Sorge, MD, President and CEO of Stratagene. "Reg has made an enormous contribution to the Company, and now that the integration of Hycor and Stratagene is complete, and we are well on our way toward executing our growth strategies, we are positioned to smoothly transition the CFO role to Steve. I personally look forward to working with Steve, and on behalf of the entire organization thank Reg for his commitment and significant contributions to the Company."
|
|
|
|
|
|
|
|
|
|
|